The effect of disease modifying therapies on fatigue in multiple sclerosis

•Fatigue is a symptom with a serious impact on patients’ quality of life.•Inclusion of fatigue as an RCT outcome is crucial to understand the impact of DMTs.•Limited RCTs of DMTs assessed fatigue as an outcome.•The reporting of PROs of DMT trials assessing fatigue is suboptimal.•Carefully considerat...

Full description

Saved in:

Bibliographic Details
Published in:	Multiple sclerosis and related disorders Vol. 79; p. 105065
Main Authors:	Cruz Rivera, Samantha, Aiyegbusi, Olalekan Lee, Piani Meier, Daniela, Dunne, Achille, Harlow, Danielle E, Henke, Christian, Kamudoni, Paul, Calvert, Melanie J
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01.11.2023
Subjects:	Disease-modifying therapies (DMTs) Fatigue Fatigue - drug therapy Fatigue - etiology Humans Multiple Sclerosis - complications Multiple Sclerosis - therapy Neurology Patient Reported Outcome Measures Patient-reported outcomes (PROs) Reference Standards Systematic Reviews as Topic Fatigue Patient-reported outcomes (PROs) Disease-modifying therapies (DMTs) patient-reported outcomes (PROs) fatigue disease-modifying therapies (DMTs)
ISSN:	2211-0348, 2211-0356, 2211-0356
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!